Catalyst Health Solutions, Inc. to Report First Quarter Financial Results on May 3, 2012
26 Abril 2012 - 2:03PM
Business Wire
Catalyst Health Solutions, Inc. (NASDAQ: CHSI) will release its
first quarter 2012 financial results on Thursday, May 3, 2012,
before the market opens.
About Catalyst Health Solutions, Inc.
(www.chsi.com):
Catalyst Health Solutions, Inc., the fastest growing national
PBM in the U.S., is built on strong, innovative principles in the
management of prescription drug benefits and provides an unbiased,
client-centered philosophy resulting in industry-leading client
retention rates. The Company's subsidiaries include Catalyst Rx, a
full-service pharmacy benefit manager (PBM) serving more than 18
million lives in the United States and Puerto Rico; HospiScript
Services, LLC, one of the largest providers of PBM services to the
hospice industry; FutureScripts, LLC, a full-service PBM serving
approximately one million lives in the mid-Atlantic region; and a
fully integrated prescription mail service facility. The Company's
clients include self-insured employers, including state and local
governments, managed care organizations, unions, hospices,
third-party administrators and individuals.
This press release may contain "forward-looking statements" as
defined in the Private Securities Litigation Reform Act of 1995.
These statements involve a number of risks and uncertainties that
might materially affect our results, particularly those risks
referred to in our Annual Report on Form 10-K for the year ended
December 31, 2011, under "Item 1A. Risk Factors." Readers are urged
to carefully review and consider the various disclosures made in
our Annual Report on Form 10-K, our Forms 10-Q, and our other
filings with the Securities and Exchange Commission that attempt to
advise interested parties of the risks and uncertainties that may
affect our business. Catalyst Health Solutions, Inc. does not
undertake any obligation to update forward-looking statements,
whether as a result of new information, future events, or other
developments.
Transaction Forward-Looking Statements
In addition, numerous factors could cause actual results with
respect to the proposed merger with SXC to differ materially from
those in the forward-looking statements, including without
limitation, the possibility that the expected efficiencies and cost
savings from the proposed merger will not be realized, or will not
be realized within the expected time period; the risk that the SXC
and Catalyst businesses will not be integrated successfully; the
ability to obtain governmental approvals of the proposed merger on
the proposed terms and schedule contemplated by the parties; the
failure of shareholders of SXC or Catalyst to approve the proposed
merger; disruption from the proposed merger making it more
difficult to maintain business and operational relationships; the
risk of customer attrition; the possibility that the proposed
merger does not close, including, but not limited to, due to the
failure to satisfy the closing conditions; and the ability to
obtain the financing contemplated to fund a portion of the
consideration to be paid in the proposed merger and the terms of
such financing.
Important Additional Information
This communication does not constitute an offer to sell or the
solicitation of an offer to buy any securities or a solicitation of
any vote or approval. This communication is being made in respect
of the proposed merger involving Catalyst and SXC. The proposed
merger will be submitted to the shareholders of Catalyst and the
shareholders of SXC for their consideration. In connection
therewith, the parties intend to file relevant materials with the
SEC, including a joint proxy statement/prospectus that will be
mailed to shareholders. Such documents, however, are not currently
available. BEFORE MAKING ANY VOTING OR INVESTMENT DECISIONS,
INVESTORS AND SECURITY HOLDERS OF CATALYST AND/OR SXC ARE URGED TO
READ THE JOINT PROXY STATEMENT/PROSPECTUS REGARDING THE PROPOSED
MERGER AND ANY OTHER RELEVANT DOCUMENTS THAT WILL BE FILED WITH THE
SEC CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE
BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED
MERGER. Investors and security holders may obtain free copies of
the proxy statement/prospectus and other documents containing
important information about Catalyst and SXC, once such documents
are filed with the SEC, through the website maintained by the SEC
at www.sec.gov. Copies of the documents filed with the SEC by SXC
will be available free of charge on SXC's website at www.sxc.com
under the heading "Investor Information" or by contacting SXC's
Investor Relations Department at 630-577-3100. Copies of the
documents filed with the SEC by Catalyst will be available free of
charge on Catalyst's website at www.catalysthealthsolutions.com
under the heading "Investor Information" or by contacting
Catalyst's Investor Relations Department at 301-548-2900.
SXC, Catalyst and certain of their respective directors,
executive officers and other members of management and employees
may be deemed to be participants in the solicitation of proxies in
connection with the proposed merger. Information about the
directors and executive officers of SXC is set forth in its proxy
statement for its 2012 annual meeting of stockholders, which was
filed with the SEC on April 2, 2012. Information about the
directors and executive officers of Catalyst is set forth in its
proxy statement for its 2011 annual meeting of shareholders, which
was filed with the SEC on April 28, 2011. These documents can be
obtained free of charge from the sources indicated above. Other
information regarding the participants in the proxy solicitation
and a description of their direct and indirect interests, by
security holdings or otherwise, will be contained in the joint
proxy statement/prospectus and other relevant materials to be filed
with the SEC when they become available.
Catalyst Health Solutions, (MM) (NASDAQ:CHSI)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Catalyst Health Solutions, (MM) (NASDAQ:CHSI)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024